ENvue Medical Partners with U-Deliver to Expand Syringe Distribution

ENvue Medical Inc. has announced a significant distribution agreement with U-Deliver, aimed at expanding the reach of its new over-the-counter reusable ENFit Syringes. This deal will enable the syringes to be distributed nationwide through non-acute care channels, providing essential support for patient feeding and medication delivery needs.

The ENFit Syringes are designed for both clinical and home care environments, addressing the growing demand for reliable healthcare solutions outside hospital settings. ENvue Medical, which recently rebranded from NanoVibronix Inc., specializes in innovative, non-invasive medical technologies. The name change reflects a strategic shift toward its primary focus on enhancing enteral care, particularly through its ENvue feeding-tube placement system.

Strategic Partnership to Enhance Market Presence

Doron Besser, CEO of ENvue Medical, stated, “We believe that our partnership with U-Deliver is an important step in scaling ENvue’s over-the-counter ENFit syringe line and strengthening our presence in the non-acute enteral care market.” This collaboration aims to bolster the company’s presence in a sector that is increasingly important for patient care continuity beyond hospital walls.

The ENFit Syringes are available in various sizes, including 2.5 mL, 5 mL, 10 mL, and 60 mL, and can be purchased without a prescription. They are designed for reuse for up to seven days or 20 uses, ensuring safe and consistent enteral delivery for patients. ENvue Medical’s products can currently be accessed through U-Deliver’s website, its Amazon storefront, and wholesale channels.

Market Performance and Future Outlook

As of March 2024, ENvue Medical’s stock is trading near the lower end of its 52-week range, which is between $0.99 and $5. Benzinga Pro reports that the stock experienced a notable increase of 20.124%, reaching $1.26 during premarket trading, with a session volume of 11.05 million shares compared to an average of 1.36 million.

This strategic distribution agreement reflects ENvue Medical’s commitment to enhancing patient care and expanding market opportunities. By focusing on safe and effective solutions for enteral feeding and medication delivery, the company aims to improve healthcare experiences for patients and caregivers alike.